Substituted pyrazinone derivatives for use as a medicine

Details for Australian Patent Application No. 2007306382 (hide)

Owner Janssen Pharmaceutica NV

Inventors Drinkenburg, Wilhelmus Helena Ignatius Maria; Vega-Ramiro, Juan Antonio; Linares De La Morena, Maria Lourdes; Oyarzabal Santamarina, Julen; PastorFernandez, Joaquin; Delgado-Jimenez, Francisca; Alcazar-Vaca, Manuel Jesus; Andres-Gil, Jose Ignacio; Martinez Gonzalez, Sonia

Agent Shelston IP

Pub. Number AU-A-2007306382

PCT Pub. Number WO2008/043775

Priority 06122173.5 12.10.06 EP

Filing date 10 October 2007

Wipo publication date 17 April 2008

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 241/20 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Event Publications

21 May 2009 PCT application entered the National Phase

  PCT publication WO2008/043775 Priority application(s): WO2008/043775

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007306384-Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the treatment of certain cancers

2007306381-Vaccine comprising an oil in water emulsion adjuvant